QT Medical, Inc.
Pulse oximetry is mandated for all 4 million newborns in the US each year-- our technology makes the screening easy, fast and low cost.
QT Medical, Inc. was incorporated in June 2013 to focus on medical devices for the pediatric and neonatal markets. We have developed a pulse oximeter specifically for newborns to screen for critical heart disease. We have been funded by NIH for the development of pulse oximeter for newborns, a compact, wireless ECG system for long QT syndrome screening, and a device for preventing sudden infant death syndrome (SIDS).